RET finger protein expression is associated with prognosis in lung cancer with epidermal growth factor receptor mutations

Pathology International

Volumn 62, Issue 5, 2012, Pages 324-330

  Iwakoshi, Akari ^a   Murakumo, Yoshiki ^a   Kato, Takuya ^a   Kitamura, Aya ^a   Mii, Shinji ^a   Saito, Shoji ^a   Yatabe, Yasushi ^b   Takahashi, Masahide ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Epidermal growth factor receptor mutation; Immunohistochemistry; Lung cancer; RET finger protein; Thyroid transcription factor 1

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN RFP; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; DNA-BINDING PROTEINS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS;

EID: 84860265022     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2012.02797.x     Document Type: Article

References (28)

1. Jemal A, Siegel R, Xu J etal. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Travis WD, Brambilla E, Noguchi M etal. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: International multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6: 244-85.
3. Wistuba II, Gazdar AF. Lung cancer preneoplasia. Annu Rev Pathol 2006; 1: 331-48.
4. Yokota J, Shiraishi K, Kohno T. Genetic basis for susceptibility to lung cancer: Recent progress and future directions. Adv Cancer Res 2010; 109: 51-72.
5. Shigematsu H, Gazdar AF. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer 2006; 118: 257-62.
6. Mitsudomi T, Morita S, Yatabe Y etal. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): An open label, randomised phase 3 trial. Lancet Oncol 2010; 11: 121-8.
7. Maemondo M, Inoue A, Kobayashi K etal. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 2010; 362: 2380-8.
8. McNab FW, Rajsbaum R, Stoye JP etal. Tripartite-motif proteins and innate immune regulation. Curr Opin Immunol 2011; 23: 46-56.
9. Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 1985; 42: 581-8.
10. Takahashi M, Inaguma Y, Hiai H etal. Developmentally regulated expression of a human'finger'-containing gene encoded by the 5?half of the ret transforming gene. Mol Cell Biol 1988; 8: 1853-6.
11. Shimono Y, Murakami H, Kawai K etal. Mi-2 beta associates with BRG1 and RET finger protein at the distinct regions with transcriptional activating and repressing abilities. J Biol Chem 2003; 278: 51638-45.
12. Krützfeldt M, Ellis M, Weekes DB etal. Selective ablation of retinoblastoma protein function by the RET finger protein. Mol Cell 2005; 18: 213-24.
13. Shimono K, Shimono Y, Shimokata K etal. Microspherule protein 1, Mi-2beta, and ret finger protein associate in the nucleolus and up-regulate ribosomal gene transcription. J Biol Chem 2005; 280: 39436-47.
14. Kato T, Shimono Y, Hasegawa M etal. Characterization of the HDAC1 complex that regulates cancer cell sensitivity to oxidative stress. Cancer Res 2009; 69: 3597-604.
15. Tsukamoto H, Kato T, Enomoto A etal. Expression of Ret finger protein correlates with outcomes in endometrial cancer. Cancer Sci 2009; 100: 1895-901.
16. Tezel G, Nagasaka T, Iwahashi N etal. Different nuclear/cytoplasmic distributions of RET finger protein in different cell types. Pathol Int 1999; 49: 881-6.
17. Yatabe Y, Kosaka T, Takahashi T etal. EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. Am J Surg Pathol 2005; 29: 633-9.
18. Kosaka T, Yatabe Y, Endoh H etal. Mutations of the epidermal growth factor receptor gene in lung cancer: Biological and clinical implications. Cancer Res 2004; 64: 8919-23.
19. Shigematsu H, Lin L, Takahashi T etal. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005; 97: 339-46.
20. Tezel G, Nagasaka T, Shimono Y etal. Differential expression of RET finger protein in testicular germ cell tumors. Pathol Int 2002; 52: 623-7.
21. Shimono Y, Murakami H, Hasegawa Y etal. RET finger protein is a transcriptional repressor and interacts with enhancer of polycomb that has dual transcriptional functions. J Biol Chem 2000; 275: 39411-9.
22. Kimura S, Hara Y, Pineau T etal. The T/ebp null mouse: Thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996; 10: 60-9.
23. Yatabe Y, Mitsudomi T, Takahashi T. TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol 2002; 26: 767-73.
24. Garber ME, Troyanskaya OG, Schluens K etal. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 2001; 98: 13784-9.
25. Bhattacharjee A, Richards WG, Staunton J etal. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001; 98: 13790-5.
26. Beer DG, Kardia SL, Huang CC etal. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002; 8: 816-24.
27. Tomida S, Koshikawa K, Yatabe Y etal. Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients. Oncogene 2004; 23: 5360-70.
28. Takeuchi T, Tomida S, Yatabe Y etal. Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol 2006; 24: 1679-88.